Rotating Nursing Beds in the USA – FDA Registration, Medicare Coverage and Medicaid

The United States is the largest single market for care beds, and it's the market where overseas suppliers most often get the paperwork wrong. Not because the rules are secret — because there are two sets of them, and they answer two different questions.

The FDA decides whether you're allowed to sell a bed in America. Medicare and Medicaid decide whether anyone will pay for it. A bed can clear the first and fail the second, and a distributor who treats an FDA number or a CE certificate as the whole story tends to find that out at the worst possible moment — at the port, or at the first claim denial.

This guide walks through both gates for rotating nursing beds sold into the USA: what the FDA requires, what Medicare bed coverage actually depends on, how Medicaid differs, and what all of it means if you're importing or specifying these products.

The two gates, and why they don't line up

It helps to keep the two agencies separate in your head, because they neither share criteria nor talk to each other.

A device can be perfectly legal to import and still be non-covered — in fact, that's the normal situation for a lot of innovative equipment. And a product that everyone agrees is useful can be illegal to sell if you skimp on FDA registration. Treat the two as separate checklists, because they are.

What the FDA treats an adjustable bed as

Under US law, an adjustable bed intended for medical purposes is a regulated device, and it's classified by how it's powered.

Both are, for most configurations, exempt from premarket notification — meaning you generally don't file a 510(k) just to sell an adjustable bed, though the exemption is conditional and accessories or connected modules can still pull a product back into 510(k) territory. That exemption trips people up: it does not mean "no FDA involvement." It means the premarket step is waived; the post-market obligations still apply.

For a foreign maker selling into the US, those obligations are the real work:

• Establishment registration — the manufacturing facility must be registered with FDA under 21 CFR Part 807.
• Device listing — the specific device, and the activities performed, must be listed.
• A US Agent — every foreign establishment must designate one; registration cannot be completed correctly without it.
• Adverse event reporting — device-related serious injuries have to be reported through MedWatch.
• Annual registration fee — for FY 2026 this is $11,423, paid to FDA between October 1 and December 31. There's no small-business discount on this particular fee.

A note on scale, because it matters when you're comparing suppliers: a 510(k) — which some higher-risk devices still require — carries a standard FY 2026 fee of $26,067. Neither figure is a reason to avoid the US market; both are reasons to know whether the product you're buying actually sits behind that paperwork or not.

The claim question that decides everything downstream

The deciding factor is something most product roadmaps skip.

Whether a rotating bed is an FDA-regulated device depends on its intended use — which in practice means what you say it does, on the label, the manual, the website, and the sales sheet. Two versions of the same bed can land in two different regulatory worlds:

• Market it for a medical purpose — relieving a diagnosed condition, replacing a hospital bed, aiding recovery — and it's a device. That brings the registration and listing duties above, and it opens the door to reimbursement if it also meets payment criteria (more on that below).
• Market it as comfort, accessibility, or furniture for daily living, with no medical claims, and it generally falls outside device regulation. That's simpler on the FDA side — but it also means no public program has a reason to pay for it, because reimbursement is built around medical need.

You can't have it both ways on the same label. The realistic framing for most rotating-bed products is that they sit closer to the furniture and independence end than to the clinical end — which is a legitimate and often better commercial position, as long as you don't then expect Medicare to write a check.

For a distributor, the practical question becomes concrete: an FDA nursing bed registration tells your customer the product is legal to place in the US. It says nothing about whether their client's insurance will cover it. Those are two conversations, and buyers who understand that trust you more, not less.

Medicare: how a bed actually gets covered

Medicare Part B covers a hospital bed as durable medical equipment (DME) — but only when very specific conditions are met, and the criteria are narrower than most first-time buyers expect.

The bed has to be DME at all. Medicare's definition requires that the item:

• withstand repeated use,
• serve a medical purpose,
• not be useful to someone who isn't sick or injured,
• be used in the home,
• be expected to last at least three years, and
• be ordered by a practitioner and supplied by an enrolled, accredited supplier.

The need has to clear the coverage criteria. The bed must be medically necessary for the individual's condition, not for comfort or convenience. In practice, the DME MAC local coverage rules recognize a handful of qualifying situations — for example, a condition that requires the body to be positioned in a way an ordinary bed can't achieve, or the head of the bed to be elevated more than 30 degrees for a cardiac or pulmonary reason, or traction that can only be mounted on a hospital bed, or a need to raise the bed's height to make transfers possible.

The feature set has to stop at semi-electric. This is the part that surprises people who make and sell powered beds:

A total electric bed — the category a rotating or fully electric hi-lo bed naturally sits in — has historically been denied on the grounds that motorized height adjustment is a convenience, not a necessity. It can still be supplied, but as an upgrade billed against a covered semi-electric bed, with the beneficiary paying the difference every month. That's a real path, but it's a narrow one.

How the money flows. Hospital beds are a capped-rental item: Medicare pays a monthly rental for up to 13 months, after which ownership transfers to the beneficiary at no further charge. Part B pays 80% of the approved amount once the annual deductible is met; the beneficiary owes the 20% coinsurance. There's no purchase option on the Medicare side — the old "buy it outright" modifiers don't apply.

What the paperwork looks like in 2026. The Certificate of Medical Necessity (CMN) forms were discontinued for dates of service on or after January 1, 2023. What the supplier now needs on file is:

• a Standard Written Order (SWO) — signed and dated by the treating practitioner, complete, and in the supplier's hands before delivery;
• clinical documentation in the medical record showing why a standard bed won't do;
• a current diagnosis code that satisfies the active coverage rule;
• a face-to-face encounter within the six months before the order; and
• proof of delivery.

Miss the SWO or the face-to-face timing and the claim is denied regardless of how appropriate the equipment was.

Where a rotating bed actually lands in this system

Put the pieces together and the conclusion is uncomfortable for anyone hoping to bill Medicare for a premium bed: the hospital-bed benefit was designed around a semi-electric twin, and a rotating bed doesn't fit neatly into it.

Two reasons:

1. There's no dedicated HCPCS code for a rotating bed. The fee schedule is built from fixed categories (the codes live in roughly the E0250–E0297 family, with side rails and mattresses coded separately). A product with no code has no guaranteed price and no clean claim path.
2. Its defining feature is fully electric. The rotation and the powered hi-lo are exactly the kind of motorized adjustment that Medicare treats as convenience when it's the height that moves.

So the practical conclusion for anyone importing rotating beds into the USA: Medicare fee-for-service is not the channel. The US public system will reimburse a basic semi-electric bed; it is not set up to reimburse a premium rotating one. Build the US business somewhere else — and there are real places to build it, which is what the next two sections are about.

Medicaid: not one program, but fifty

Medicaid is where the US gets genuinely state-by-state, because there's no single federal benefit. What's covered depends on the state, the waiver, and the assessment — and that's the complication in one sentence.

The state-plan route. Many states cover durable medical equipment, including hospital beds, through their Medicaid home-health benefit. This tends to mirror Medicare's logic: medical necessity, prior authorization, a prescribing practitioner, and a capped budget.

The waiver route, which is more interesting for a rotating bed. Medicaid's Home and Community-Based Services (HCBS) authorities — chiefly 1915(c) waivers, plus the 1915(i) state-plan option and the 1915(k) Community First Choice option in participating states — are explicitly built to keep people out of institutions. Their service lists frequently include:

• environmental accessibility adaptations (home modifications — ramps, wider doorways, and often bed-related changes),
• assistive technology and devices, and
• specialized medical equipment that reduces the need for human help.

That third item is close to a description of a rotating bed, and several states name equipment of this kind in their waiver documents. Because states use functional language ("reduces the need for physical assistance") rather than pure diagnosis codes in many waivers, a product that improves independence can qualify even when it makes no clinical claim.

The catches are real. Waivers are not entitlements — they have enrollment caps and waitlists, some of them years long. Almost all require prior authorization. And the service names are inconsistent: what one state calls "environmental accessibility adaptation," another calls "specialized medical equipment," and a third doesn't cover it at all. If you're a distributor, the work is genuinely state-by-state; there's no shortcut.

If you intend to bill: the supplier side of the fence

Whether you're a US distributor or an overseas maker setting up a US entity, the rules for billing are separate from the rules for building.

To be paid by Medicare, a supplier has to become a DMEPOS supplier, which means:

• Accreditation by a CMS-approved accreditation organization — this is a precondition for enrollment, not an optional quality badge;
• Enrollment via the CMS-855S application, submitted through PECOS;
• a separate NPI for each physical location (a DMEPOS quirk — every location enrolls on its own);
• a $50,000 surety bond per NPI;
• an application fee ($750 for 2026) for initial enrollment or revalidation;
• compliance with the 30 DMEPOS supplier standards; and
• revalidation every three years — sooner than for most other provider types.

A proposed federal rule issued in July 2025 would tighten this further, with more frequent surveys and accreditation reviews and new oversight of the accreditation bodies themselves. The direction of travel is more scrutiny, not less.

One piece of good news on competitive bidding. Hospital beds were part of past DMEPOS competitive bidding rounds, and for a while that created pricing uncertainty. As of the current program, hospital beds are not included in the next bidding round — CMS's 2026 round is limited to mail-order categories like continuous glucose monitors and certain braces and supplies. So the near-term competitive-bidding pressure on beds is off, even as accreditation pressure stays on.

What this means if you're importing or specifying

The US is still worth the effort — it's the biggest market and it rewards suppliers who understand the rules. But the strategy has to match the reality of the payment system.

For distributors:

• Position the product truthfully. If it's a comfort and independence product, say so; the US private-pay and DTC markets are large, and they don't need a medical claim to buy.
• Treat Medicaid HCBS waivers as the main public pathway, not Medicare. That means knowing a handful of state waivers well rather than all fifty shallowly.
• Don't build a US business plan on Medicare fee-for-service for a rotating bed. It's the wrong product for that benefit, and a plan that assumes otherwise will stall.
• Get the FDA registration and US Agent right early — it's cheap relative to the cost of a shipment stuck at the port.

For facilities and home-care buyers:

• Ask which HCPCS code your supplier expects to bill, and be skeptical of anyone who says a rotating bed is "Medicare-covered" without naming the code. That's usually a sign they haven't checked.
• For private-pay and Medicaid-waiver placements, the calculation is different: compare total cost over the bed's life, not invoice price, because you're the one absorbing maintenance and downtime.

As a rotating home care bed manufacturer, we see both sides of this: the products that travel well into the US are the ones whose claims match their label, and the partners who succeed there are the ones who pick the channel before they pick the price. We'd rather give a distributor a straight "no" on Medicare up front than have them find out a container too late. Saying so early is what keeps a partnership going past the first order.

A short checklist before you ship to the USA

The US market doesn't punish suppliers for asking questions. It punishes them for skipping steps they didn't know existed. Work the two gates — legality, then payment — and the rest follows.

Part of our market guides for the USA. AIDASTRA builds rotating beds, nursing beds and mobility aids for home care, facilities and distribution partners; our beds are documented to IEC 60601-2-52 and supported with the registration materials US importers need. If you're planning a US launch, tell us the channel you're targeting — private pay, facility, or Medicaid waiver — and we'll tell you what the rules require and where the product realistically fits.

Related Reading

→ FAQ: Which Global Certifications Do Nursing Beds Need?
→ SGS Certification Explained
→ Home Care vs. Nursing Homes — The 2026 Market Reality
→ FAQ: Nursing Bed Total Cost of Ownership
→ B2B Partnership Guide — OEM & ODM

Sources

• 21 CFR 880.5100 — AC-powered adjustable hospital bed (Class II, product code FNL). eCFR
• 21 CFR 880.5110 — Hydraulic adjustable hospital bed (Class I, product code FNK). eCFR
• FDA — Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment (2006), and adult portable bed rail safety information for manufacturers; FDA-recognized consensus standard IEC 60601-2-52. FDA guidance · FDA bed rails
• FDA — Establishment registration and device listing; Device Facility User Fee (annual registration fee $11,423; standard 510(k) fee $26,067 for FY 2026); US Agent requirement under 21 CFR Part 807. FDA device registration & listing
• CMS / Medicare — Durable medical equipment (DME) coverage; hospital beds as capped-rental DME with 13-month rental then transfer of ownership; 80/20 coinsurance. Medicare.gov — DME · CMS — DMEPOS
• DME MAC / Noridian — Supplier documentation: Standard Written Order, face-to-face encounter within six months, and the discontinuation of CMN/DIF forms for dates of service on or after January 1, 2023. Noridian — supplier documentation
• 42 CFR Part 424 Subpart F — DMEPOS supplier standards (424.57) and accreditation requirement (424.58). eCFR — 42 CFR Part 424
• Federal Register — CY 2026 Home Health PPS / DMEPOS final rule (90 FR 29108, July 2, 2025), including DMEPOS accreditation and competitive bidding updates. Federal Register
• ASPE (HHS) — Compendium of Home Modification and Assistive Technology Policy and Practice Across States; and KFF, Key State Policy Choices About Medicaid Home and Community-Based Services. ASPE · KFF